Friday, July 10, 2026

Drug profile · INN

phenelzine sulfate

phenelzine sulfate (PHENELZINE SULFATE) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — phenelzine sulfate
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.84

Quick answer

phenelzine sulfate (PHENELZINE SULFATE) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN phenelzine sulfate
Brand PHENELZINE SULFATE
Mechanism Monoamine oxidase inhibitor
Target Monoamine oxidase
Route ORAL
Formulation TABLET

Mechanism of action

Monoamine oxidase inhibitor

Primary target: Monoamine oxidase

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. isocarboxazid Monoamine oxidase inhibitor
  2. pargyline hydrochloride Monoamine oxidase inhibitor
  3. tranylcypromine sulfate Monoamine oxidase inhibitor

Frequently asked questions

What is phenelzine sulfate?

phenelzine sulfate (PHENELZINE SULFATE) is a monoamine oxidase inhibitor. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for phenelzine sulfate?

PHENELZINE SULFATE is a marketed brand name for phenelzine sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of phenelzine sulfate?

phenelzine sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.